Certified by Founder Lodge
Neuron23
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $96,500,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines r
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 26 ,2025 | Series D | $96,500,000 |
Acorn Bioventures
Blue Owl Capital
Redmile Group
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
